Screening for neurocognitive impairment, depression, and anxiety in HIV-infected patients in Western Europe and Canada
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
CRANIum, a cross-sectional epidemiology study in Western Europe and Canada, was conducted to describe and compare the prevalence of a positive screen for neurocognitive impairment (NCI), depressive symptoms, and anxiety in an HIV-positive population either receiving combination antiretroviral therapy (cART) or who were naive to antiretroviral therapy (ART). HIV-positive patients ≥18 years of age attending a routine medical follow-up visit and able to complete the designated screening tools were eligible for study inclusion. The Brief Neurocognitive Screen was used to assess NCI; depressive and anxiety symptoms were assessed using the Hospital Anxiety and Depression Scale. The evaluable patient population (N = 2863) included 1766 men (61.7%) and 1096 (38.3%) women. A total of 1969 patients were cART-experienced (68.8%), and 894 were ART-naive (31.2%). A positive screen for NCI was found in 41.5% of patients (cART-experienced, 42.5%; ART-naive, 39.4%; p = 0.12). A positive screen for depressive symptoms was found in 15.7% of patients (cART-experienced, 16.8%; ART-naive, 13.3%; p = 0.01), whereas 33.3% of patients screened positive for anxiety (cART-experienced, 33.5%; ART-naive, 32.8%; p = 0.71). A greater percentage of women compared with men screened positive for NCI (51.78% vs. 35.1%; p < 0.0001) and depressive symptoms (17.9% vs. 14.3%; p = 0.01). These data suggest that neurocognitive and mood disorders remain highly prevalent in HIV-infected patients. Regular mental health screening in this population is warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heaton, R. K., Clifford, D. B., Franklin, D. R., Woods, S. P., Ake, C., Vaida, F., Ellis, R. J., Letendre, S. L., Marcotte, T. D., Atkinson, J. H., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e318200d727 · Cited by 2,353
Bing, E. G., Burnam, M. A., Longshore, D., Fleishman, J. A., Sherbourne, C. D., London, A. S., Turner, B. J., Eggan, F., Beckman, R., Vitiello, B., et al. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.8.721 · Cited by 1,255 · cited 3×
“Screening for neurocognitive impairment, depression, and anxiety in HIV-infected patients in Western Europe and Canada Kevin Robertsona, Carmen Bayonb, Jean-Michel Molinac,d, Patricia McNamarae, Christiane Reschf, Jose A. Muñoz-Morenog, Ranjababu Kulasegaramh, Knud Schewei, Angel Burgos-Ramirezj, Cristina De Alvaroj,…”
BackgroundDepressive disorders in Europe: prevalence figures from the ODIN study
Ayuso-Mateos, J. L., Vázquez-Barquero, J. L., Dowrick, C., Lehtinen, V., Dalgard, O. S., Casey, P., Wilkinson, C., Lasa, L., Page, H., Dunn, G., et al. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.179.4.308 · Cited by 564 · cited 3×
“Depressive and anxiety symptomatology were assessed using the self-administered Hospital Anxiety and Depression Scale (HADS) questionnaire, which consists of seven items each relating to depression (HADS-D) and anxiety (HADS-A), respectively.”
MethodResultInfluentialLoneliness and HIV-related stigma explain depression among older HIV-positive adults
Grov, C., Golub, S. A., Parsons, J. T., Brennan, M., & Karpiak, S. E. (2010) · AIDS Care · doi:10.1080/09540120903280901 · Cited by 381
Depression Treatment Enhances Adherence to Antiretroviral Therapy: a Meta-Analysis
Sin, N. L., & DiMatteo, M. R. (2014) · Annals of Behavioral Medicine · doi:10.1007/s12160-013-9559-6 · Cited by 266
Gaynes, B. N., Pence, B. W., Eron, J. J., & Miller, W. C. (2008) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31816aa0cc · Cited by 143
Cited by
Depression in HIV Infected Patients: a Review
Nanni, M. G., Caruso, R., Mitchell, A. J., Meggiolaro, E., & Grassi, L. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-014-0530-4 · Cited by 511
Prevalence, impact, and management of depression and anxiety in patients with HIV: a review
Chaudhury, S., Bakhla, A., & Saini, R. (2016) · Neurobehavioral HIV Medicine · doi:10.2147/nbhiv.s68956 · Cited by 54
“Similarly, the prevalence of an anxiety disorder in PLWHA is more common than in the general population.(5) Depression and anxiety are associated with an increase in morbidity and mortality in PLWHA and adversely affect the adherence to antiretroviral therapy (ART), quality of life (QoL), and health-related QoL.”
Prevalence and correlates of psychological distress of middle-aged and older women living with HIV
Monteiro, F., Canavarro, M. C., & Pereira, M. (2017) · Psychology, Health & Medicine · doi:10.1080/13548506.2017.1281972 · Cited by 13
Metadata
- Authors
- Robertson, K., Bayon, C., Molina, J.-M., McNamara, P., Resch, C., Muñoz-Moreno, J. A., Kulasegaram, R., Schewe, K., Burgos-Ramirez, A., De Alvaro, C., Cabrero, E., Guion, M., Norton, M., & van Wyk, J.
- Venue
- AIDS Care
- Publisher
- Informa UK Limited
- Published
- 2014-07-16
- Volume
- 26
- Issue
- 12
- Pages
- 1555-1561
- ISSN
- 0954-0121 (ISSN-L)
- 1360-0451
- OpenAlex
- W2122393914
- Cited by
- 112
- References
- 6
- FWCI
- 4.56
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Screening for neurocognitive impairment, depression, and anxiety in HIV-infected patients in Western Europe and Canada. https://app.cochat.ai/papers/10.1080/09540121.2014.936813
- The paper
- Robertson, K., Bayon, C., Molina, J.-M., McNamara, P., Resch, C., Muñoz-Moreno, J. A., Kulasegaram, R., Schewe, K., Burgos-Ramirez, A., De Alvaro, C., Cabrero, E., Guion, M., Norton, M., & van Wyk, J. (2014). Screening for neurocognitive impairment, depression, and anxiety in HIV-infected patients in Western Europe and Canada. AIDS Care. https://doi.org/10.1080/09540121.2014.936813
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.